Eases. Chest 2012, 142:1289299. Chung KF, Marwick JA: Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci 2010, 1203:851. Barnes PJ: New anti-inflammatory targets for chronic obstructive pulmonary illness. Nat Rev Drug Discov 2013, 12:54359. p38 MAPK Agonist Purity & Documentation Sloane PA, Shastry S, Wilhelm A, Courville C, Tang LP, Backer K, Levin E, Raju SV, Li Y, Mazur M, Byan-Parker S, Grizzle W, Sorscher EJ, Dransfield MT, Rowe SM: A pharmacologic strategy to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking associated lung illness. PLoS A single 2012, 7:e39809. Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, Gaggar A, Steele C, Tang LP, Liu B, Rowe SM: Acquired cystic fibrosis transmembrane conductance regulator dysfunction inside the lower airways in COPD. Chest 2013, 144:49806. Croxton TL, Weinmann GG, Senior RM, Hoidal JR: Future research directions in chronic obstructive pulmonary illness. Am J Respir Crit Care Med 2002, 165:83844. Marcorelles P, Montier T, Gillet D, Lagarde N, Ferec C: Evolution of CFTR protein distribution in lung tissue from standard and CF human fetuses. Pediatr Pulmonol 2007, 42:1032040. Fang X, Song Y, Hirsch J, Galietta LJ, Pedemonte N, Zemans RL, Dolganov G, Verkman AS, Matthay MA: Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells. Am J Physiol Lung Cell Mol Physiol 2006, 290:L242 249. Smith CJ, Livingston SD, Doolittle DJ: An international literature survey of “IARC Group I carcinogens” reported in mainstream cigarette smoke. Food Chem Toxicol 1997, 35:1107130.32. Paakko P, Anttila S, Kokkonen P, Kalliomaki PL: PLK1 Inhibitor Species cadmium in lung tissue as marker for smoking. Lancet 1988, 1:477. 33. Chambers RC, Laurent GJ, Westergren-Thorsson G: Cadmium inhibits proteoglycan and procollagen production by cultured human lung fibroblasts. Am J Respir Cell Mol Biol 1998, 19:49806. 34. Abu-Hayyeh S, Sian M, Jones KG, Manuel A, Powell JT: Cadmium accumulation in aortas of smokers. Arterioscler Thromb Vasc Biol 2001, 21:86367. 35. Roels H, Lauwerys R, Buchet JP, Genet P, Sarhan MJ, Hanotiau I, de Fays M, Bernard A, Stanescu D: Epidemiological survey amongst workers exposed to manganese: effects on lung, central nervous technique, and some biological indices. Am J Ind Med 1987, 11:30727. 36. Mahoney JP, Modest WJ: Research on manganese. three. The biological half-life of radiomanganese in man and components which affect this half-life. J Clin Invest 1968, 47:64353. 37. Mannino DM, Holguin F, Greves HM, Savage-Brown A, Stock AL, Jones RL: Urinary cadmium levels predict reduce lung function in present and former smokers: information in the Third National Overall health and Nutrition Examination Survey. Thorax 2004, 59:19498. 38. Davison AG, Fayers PM, Taylor AJ, Venables KM, Darbyshire J, Pickering CA, Chettle DR, Franklin D, Guthrie CJ, Scott MC: Cadmium fume inhalation and emphysema. Lancet 1988, 1:66367. 39. Kirschvink N, Martin N, Fievez L, Smith N, Marlin D, Gustin P: Airway inflammation in cadmium-exposed rats is related to pulmonary oxidative pressure and emphysema. Free Radic Res 2006, 40:24150. 40. Kirschvink N, Vincke G, Fievez L, Onclinx C, Wirth D, Belleflamme M, Louis R, Cataldo D, Peck MJ, Gustin P: Repeated cadmium nebulizations induce pulmonary MMP-2 and MMP-9 production and emphysema in rats. Toxicology 2005, 211:368.doi:10.1186/1465-9921-15-69 Cite this short article as: Hassan et.